Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-18

FDA Approved: ESTRADIOL AND NORETHINDRONE ACETATE — Supplemental Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Estradiol and Norethindrone Acetate from Ingenus Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ESTRADIOL AND NORETHINDRONE ACETATE (ESTRADIOL AND NORETHINDRONE ACETATE)

Snippet

SUPPL AP for ESTRADIOL AND NORETHINDRONE ACETATE (ESTRADIOL AND NORETHINDRONE ACETATE)